Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Influenza

Free Subscription 18.08.2025 3 Antiviral Res 1 Arch Virol 3 Biochem Biophys Res Commun 2 Cell 1 Epidemiol Infect 2 J Infect Dis 3 J Virol 2 Pediatrics 2 PLoS Comput Biol 9 PLoS One 1 Proc Natl Acad Sci U S A 1 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antiviral Res

1. AL KRAD D, Stegmann KM, Dickmanns A, Kumar P, et al
   The protease inhibitor Nirmatrelvir synergizes with inhibitors of GRP78 to suppress SARS-CoV-2 replication.
   Antiviral Res. 2025 Jul 29:106247. doi: 10.1016/j.antiviral.2025.106247.
   PubMed         Abstract available
   
   
2. PATEL D, De R, Azadi N, Lee S, et al
   Discovery of broad-spectrum antivirals targeting viral proteases using in silico structural modeling and cellular analysis.
   Antiviral Res. 2025;241:106245.
   PubMed         Abstract available
   
   
3. LEBEDIN M, Petrovsky N, Tabynov K, Tabynov K, et al
   SARS-CoV-2 neutralization and protection of hamsters via nasal administration of a humanized neutralizing antibody.
   Antiviral Res. 2025;241:106235.
   PubMed         Abstract available
   
   

   
   Arch Virol

4. FERNANDEZ-ROJAS MA, Salazar AM, Ostrosky-Wegman P, Flisser A, et al
   A feedback loop between DNA damage, genomic instability, and cytoplasmic DNA sensing contributes to cytokine production in COVID-19.
   Arch Virol. 2025;170:192.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

5. ZHU H, Chen J, Dong X, Qin X, et al
   Influence of dihydrocaffeic acid and quinic acid on lung metabolism and function: Implications for dietary interventions.
   Biochem Biophys Res Commun. 2025;777:152274.
   PubMed         Abstract available
   
   
6. HODYNA D, Gryniukova A, Rogalsky S, Borysko P, et al
   Ionic liquids and lysosomotropic detergents as inhibitors of the SARS-CoV-2 main protease: QSAR modeling, synthesis and biological testing.
   Biochem Biophys Res Commun. 2025;777:152276.
   PubMed         Abstract available
   
   
7. ZHENG WH, Ni RZ, Ran XH, Mu D, et al
   Papain-like protease of SARS-CoV-2 inhibits dsRNA-induced type I interferon response partly by cleaving TBK1.
   Biochem Biophys Res Commun. 2025;777:152244.
   PubMed         Abstract available
   
   

   
   Cell

8. HUANG Y, Tan L, Liu Y, Zhao H, et al
   Response to: The mechanism for GTP-mediated RNA capping by the SARS-CoV-2 NiRAN domain remains unresolved.
   Cell. 2025;188:4462-4469.
   PubMed         Abstract available
   
   
9. SMALL GI, Darst SA, Campbell EA
   The mechanism for GTP-mediated RNA capping by the SARS-CoV-2 NiRAN domain remains unresolved.
   Cell. 2025;188:4456-4461.
   PubMed         Abstract available
   
   

   
   Epidemiol Infect

10. SMAGGE B, Labuschagne L, Pijpers J, van Roon A, et al
    Factors associated with lower COVID-19 vaccine uptake among populations with a migration background in the Netherlands.
    Epidemiol Infect. 2025;153:e87.
    PubMed         Abstract available
    
    

    
    J Infect Dis

11. ESPERSEN C, Johansen ND, Modin D, Janstrup KH, et al
    Relative effectiveness of high-dose versus standard-dose influenza vaccine against hospitalizations and mortality according to frailty score: A post-hoc analysis of the DANFLU-1 randomized trial.
    J Infect Dis. 2025 Aug 13:jiaf420. doi: 10.1093.
    PubMed         Abstract available
    
    
12. WONG JY, Cheung JK, Iuliano AD, Wu P, et al
    Influenza-associated excess mortality associated with influenza B in Hong Kong, 2014-2023.
    J Infect Dis. 2025 Aug 6:jiaf414. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Virol

13. YAN Y, Xu J, Chen Z, Xu Y, et al
    Heat shock protein A1L restricts influenza A virus by ubiquitination of NA.
    J Virol. 2025 Aug 11:e0077125. doi: 10.1128/jvi.00771.
    PubMed         Abstract available
    
    
14. KELVIN AA, Baker PH, Ghosh S, Schultz-Cherry S, et al
    Influenza infection of the mammary gland.
    J Virol. 2025 Aug 12:e0194024. doi: 10.1128/jvi.01940.
    PubMed         Abstract available
    
    
15. DZIMIANSKI JV, Nagashima KA, Cruz JM, Sautto GA, et al
    Assessing the structural boundaries of broadly reactive antibody interactions with diverse H3 influenza hemagglutinin proteins.
    J Virol. 2025 Aug 14:e0045325. doi: 10.1128/jvi.00453.
    PubMed         Abstract available
    
    

    
    Pediatrics

16. ANTOON JW
    Influenza Antivirals: Do We Need More Evidence?
    Pediatrics. 2025 Aug 13:e2025071863. doi: 10.1542/peds.2025-071863.
    PubMed        
    
    
17. BASSETT HK, Rao S, Beck J, Brady PW, et al
    Clinician Preferences for Oseltamivir Use in Children With Influenza in the Outpatient Setting.
    Pediatrics. 2025 Aug 13:e2025071193. doi: 10.1542/peds.2025-071193.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

18. SCIANNA M, Gallotti R, Tizzoni M, Artime O, et al
    Comparing the effectiveness of ring and block-vaccination strategies on networks.
    PLoS Comput Biol. 2025;21:e1013274.
    PubMed         Abstract available
    
    
19. TIZZANI M, Gauvin L
    Socioeconomic determinants of protective behaviors and contact patterns in the post-COVID-19 pandemic era: A cross-sectional study in Italy.
    PLoS Comput Biol. 2025;21:e1013262.
    PubMed         Abstract available
    
    

    
    PLoS One

20. NAROUEI FH, Tang Z, Wang SI, Hashmi RH, et al
    Effects of germicidal far-UVC on ozone and particulate matter in a conference room.
    PLoS One. 2025;20:e0328224.
    PubMed         Abstract available
    
    
21. WYPLOSZ B, Grenier B, Roche N, Roubille F, et al
    Pneumococcal vaccination at 65 years and vaccination coverage in at-risk adults: A retrospective population-based study in France.
    PLoS One. 2025;20:e0329703.
    PubMed         Abstract available
    
    
22. SOEDER J, Preiser C, Wagner A, Neunhoffer AT, et al
    Pandemic preparedness in shaping psychosocial working conditions - insights for occupational safety and health from a longitudinal mixed-methods study during the COVID-19 pandemic at six company sites of one organization in Germany.
    PLoS One. 2025;20:e0328410.
    PubMed         Abstract available
    
    
23. BHAGAVATHI V, Ogum D, Agyabeng K, Coker-Appiah D, et al
    Unchanged but undecided: Reproductive intentions among Ghanaian women following COVID-19 lockdowns in two large metropolises in Ghana.
    PLoS One. 2025;20:e0328298.
    PubMed         Abstract available
    
    
24. TOUZET H, Privault S, Ward JK
    The role of professional socialisation in confidence in vaccines and vaccination decision-makers: Insights from a large multi-wave survey in France.
    PLoS One. 2025;20:e0328548.
    PubMed         Abstract available
    
    
25. RASMUSSEN MGB, Just-Ostergaard E, Stidsen JV, Willaing I, et al
    What is the impact of structural changes in society on diabetes self-management and trajectories of HbA1c? A cohort study before, during and after the COVID-19 pandemic in people with diabetes treated at outpatient clinics.
    PLoS One. 2025;20:e0329394.
    PubMed         Abstract available
    
    
26. ROY S, Biswas P, Ghosh P
    Advancing infection profiling under data uncertainty through contagion potential.
    PLoS One. 2025;20:e0329828.
    PubMed         Abstract available
    
    
27. MO J, Ferreri LM, Geiger G, Perez DR, et al
    Passage of human-origin influenza A virus in swine tracheal epithelial cells selects for adaptive mutations in the hemagglutinin gene.
    PLoS One. 2025;20:e0327096.
    PubMed         Abstract available
    
    
28. PRASERT K, Praphasiri P, Ditsungnoen D, Srichaijaroonpong S, et al
    Perceptions of influenza and SARS-CoV-2 vaccination among health care personnel in Thailand, 2024.
    PLoS One. 2025;20:e0329473.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

29. XU Y, Anirudhan V, Gaisina IN, Du H, et al
    Mechanistic insights into the small-molecule inhibition of influenza A virus entry.
    Proc Natl Acad Sci U S A. 2025;122:e2503899122.
    PubMed         Abstract available
    
    

    
    Vaccine

30. ASHRAF M, Stein AN, Youhanna J, Rockman S, et al
    The impact of egg adaptation and immune imprinting on influenza vaccine effectiveness.
    Vaccine. 2025;62:127393.
    PubMed         Abstract available
    
    

    
    Virology

31. CHERNYSHOVA AI, Zhirnov OP
    Influenza A virions with uncleaved hemagglutinin HA0 are more resistant to thermal inactivation than those with cleaved HA1/2: Research and applied significance.
    Virology. 2025 Jul 26:110644. doi: 10.1016/j.virol.2025.110644.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.